Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry.
about
Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments.Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.High competing risks minimize real-world utility of adjuvant targeted therapy in renal cell carcinoma: a population-based analysis.
P2860
Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Variation in use of targeted t ...... tch population-based registry.
@ast
Variation in use of targeted t ...... tch population-based registry.
@en
type
label
Variation in use of targeted t ...... tch population-based registry.
@ast
Variation in use of targeted t ...... tch population-based registry.
@en
prefLabel
Variation in use of targeted t ...... tch population-based registry.
@ast
Variation in use of targeted t ...... tch population-based registry.
@en
P2093
P2860
P1433
P1476
Variation in use of targeted t ...... utch population-based registry
@en
P2093
C A Uyl-de Groot
E Oosterwijk
J B A G Haanen
S De Groot
S Sleijfer
W K Redekop
P2860
P2888
P356
10.1186/S12885-016-2395-X
P407
P577
2016-06-11T00:00:00Z
P6179
1005351769